It is well established now that in diseases with activated cell-mediated immunity increased formation of neopterin and degradation of tryptophan is an indication of endogenous production of interferon-γ in patients. Therefore increased neopterin levels are associated with increased kynuremne levels and decreased tryptophan in patients suffering from virus infections, malignant diseases or autoimmunity. To investigate cell-mediated immunity m schizophrenia, neopterin, L-kynurenine, L-tryptophan and T-cell-subsets were measured in 10 chronic schizophrenic patients, addmitted to hospital due to acute psychiatric relapse. Low neopterin concentrations were found at the beginning of hospitalisation and followed by a significant increase at the time of discharge (p -0.02). Mean neopterin values were still within the 95"· percentile of healthy controls. Kynuremne levels showed a similar development (p = 0.03) as neopterin whereas tryptophan values were low at admission without any significant changes thereafter. CD3 + and CD4+-cells presented with highest numbers at admission, followed by a continuous decrease and NK-cells were found lowest on day 0 with a gradual increase by day 7. These findings argue against acute virus infection in acutely ill schizophrenic patients because this would be associated with incerased neopterin fromation and tryptophan dagradation, rather the data would be in line with a shift from TH-1 to TH-2-type immune reaction which which is common in chronic infections.
Introduction
Involvement of the immune system in the pathophysiology of schizophrenia has been the focus of numerous studies (1) . Although results are controversial and sometimes not at all conclusive, there are at least three hypotheses which seem to be worth pursuing. These investigate: a) a potential autoimmune process in schizophrenic disorder (2-4) b) a viral or even slow virus infection being the cause of schizophrenic illness (5-8) and c) immunologic dysregulations of the T-cell system (9) (10) (11) .
Since cell-mediated immunity (CMI) is primarily addressed in these three immunologic hypotheses a clinical study applying a marker of CMI can be considered as a promising approach. Neopterin is a low molecular mass compound biosynthetically derived from guanosme triphosphate.Neopterin is released in large quantities mainly by activated cells of the monocyte/macrophage lineage which have been stimulated by interferon-γ (IFN-γ) derived from activated T-cells, (12) (13) (14) (15) . Thus, increased neopterin secretion is a sensitive marker of activation of CMI (16) . Elevated neopterin levels in blood and urine have been measured in numerous diseases where CMI is activated such as in viral or chronic bacterial infections (13, 14) and autoimmune disorders (17, 18) .
Recently, there has been evidence that high neopterin representing activated CMI e.g. in inflammatory diseases is positively correlated with L-kynuremne indicating a relationship between accelerated kynurenine pathway metabolism and the degree of immune stimulation. L-tryptophan is converted to L-kynurenine by the action of tryptophan-2,3-dioxygenase (tryptophan pyrrolase) in the liver, and indoleamine-2,3-dioxygenase (IDO) in extrahepatic tissues, inclu- (15, 20) . In human monocytes/macrophages it was demonstrated that kynurenine formed from tryptophan due to activation of IDO is further catabolized to anthranilic acid and 3-hydroxyanthranilic acid (19) and later on also quinolinic acid was shown to accumulate (20) . It is now well established that in a variety of cells IDO activity is inducible by IFN-γ (21). Since IFN-γ stimulates both enzymepathways in parallel, namely the degradation of tryptophan by the IDO and the biosynthesis of neopterin from GTP, a strong correlation between increased neopterin and increased kynurenine concentrations on one hand and decreased tryptophan concentrations on the other hand can be observed. In various diseases with an activation of CMI, e.g. patients with HIV-1 infection, increased neopterin and kynurenine concentrations but diminished tryptophan levels were shown (22) . The highest degree of correlation was found between neopterin, IFN-γ and the kynurenine per tryptophan ratio which implies that the activated IDO is involved in this metabolic changes.
In order to investigate the activation of CMI in patients with schizophrenia we measured neopterin, tryptophan, kynurenine and T-cell subsets in serum.
Materials and Methods
Ten patients, 4 female and 6 male, suffering from chronic schizophrenia (DSM-IV) who had been admitted to hospital due to acute psychotic relapse have been allocated to this study. Physical illness that might have influenced immune functions as well as drug and alcohol abuse were exclusion criteria. Informed consent according to the declaration of Helsinki was obtained by all patients. The age of the patients was between 23 and 48 with a mean of 32.3 years and duration of schizophrenic illness ranged from 3 to 28 years (mean 9.7 years).
All patients had been pretreated with antipsychotics before but 4 of them had discontinued to take medication during the weeks prior to admission. These 4 patients had a period without antipsychotic treatment of 1 -3 weeks. Neuroleptic treatment (8 patients on risperidone, 2 patients on haloperidol) was started respectively continued on the first day of hospitalisation (= day 0). On the same day a physical examination took place, including a urinary drug screen, followed by an evaluaton of psychopathology by using the Brief Psychiatric Rating Scale (BPRS). On this morning at approximately 7.30 blood was drawn by venopuncture. Besides routine laboratory tests, T-cell subsets (CD3+, CD4+, CD8+, ratio, NK-cells) using FACS-analysis and the concentrations of neopterin (ELISA, BRAHMS, Berlin, Germany), tryptophan and kynurenine by HPLC (23) were measured in serum on day 0 (=admission to hospital), after seven days of antipsychotic treatment and on the day of discharge. On the same days psychopathology was assessed by the BPRS. The time of hospitalisation was 35 ± 7 days.
Ten age-and sex-matched and physically and mentally healthy volunteers served as controls. None of them was a regular drinker or had ever taken antipsychotic drugs.
For statistical analysis the Mann-Whitney U-test (comparison between schizophrenic patients and healthy controls), the Wilcoxon matched pairs signed 
Results
Changes during treatment: Lowest neopterin concentrations were found on day 0, followed by a significant increase by the end of treatment (p=0.02), however neopterin values remained within the 95th percentile of age-matched healthy controls (neopterin < 8.7nmol/l) (Tab. 1).
Kynurenine levels showed a similar development as neopterin, starting with lowest values on the day of admission, which was followed by a significant increase during antipsychotic treatment (day 7: p=0.02, discharge: p=0.03; Tab. 1).
Tryptophan concentrations were low at admission without any significant changes thereafter and only a slight non-significant increase on day 7 (Tab. 1).
The kynurenine to tryptophan ratio paralleled kynurenine and neopterin levels with the lowest value at day 0 and a slight increase at the end of treatment without reaching statistical significance.
There was never a statistically relevant change of total leuko-and lymphocytes during the treatment period (Tab. 2). Patients presented with highest T-cellsubsets, CD3+ and CD4+cells numbers at admission, followed by a continuous decrease but without reaching statistical significance. Vice versa NK-cells were lowest on day 0 and gradually increased on day 7 and at discharge (p=n.s.) (Tab. 2).
As exspected highest BPRS total scores were found on day 0 and lowest on the day of discharge from hospital. Neopterin and kynurenine levels showed the reverse depelopment and statistically an inverse correlation could be observed between BPRS total scores and these 2 biological parameters on day 0 as well as at the end of hospitalisation period.
Comparisons between patients and healthy controls: Neopterin concentrations did not differ between patients and controls on day 0, by day 7 patients tended to have higher values than controls (p=0.06) and at the end of treatment this increase was statistically significant (p=0.03; Tab. 1). Similar findings apply to kynurenine levels: by day 7 the comparison between patients and controls revealed significantly higher values in schizophrenic patients (p=0.02). By the end of treatment this difference was even more evident (p=0.01). Tryptophan levels did not differ between patients and controls at any time of the investigation. The kynurenine per tryptophan quotient was higher in the schizophrenic group (p=0.04) at the end of treatment.
The comparison of the total number of white blood cells, and of total lymphocytes between schizophrenic patients and healthy controls showed no differences (Tab. 2). T-cell subsets revealed no statistical difference between patients and controls at any time of the investigation with the exception of NK-cells where significatly lower values were measured in patients on day 0 (p=0.04). Ν o differences could be observed on day 7 and at the time of discharge (Tab. 2).
Discussion
Neopterin data of this study confirm our previous reports (9, 24) in which we had described lowest p' changes during treatment p° comparison between schizophrenic patients and healthy controls neopterin concentrations in the acute stages of the illness followed by a slight increase concomitant to a continous improvement of psychopathology. Despite this slight increase in neopterin, which consequently lead to a significant difference between schizophrenic patients and healthy controls during the observation period (admission to discharge), this study does not support the hypothesis of CMI activation in acute schizophrenia because neopterin concentrations still remained within the 95th percentile of age-and sexmatched controls. In accordance with our previous investigations (9, 24) and with data published by Dunbar et al. (25) these results argue against the active involvement of viruses in the etiology of acute schizophrenia, since neopterin as sensitive marker presents with much higher values in patients with viral infections than those found in this study (13) . Similarly, the mainly normal neopterin values measured in these acutely ill schizophrenic patients stand in marked contrast to the elevations observed in autoimmune diseases (13) It is important to note, however, that while CMI does not appear to be activated in these patients, the possibility remains that CMI might have been active earlier in the course of their illness, perhaps causing damage well before schizophrenia was clinically evident. Therefore results do not contradict a potential involvement of viral infections as discussed in various reports studying correlations between schizophrenia and maternal influenza (26) . Although, neither our group (9, 24) nor Dunbar et al. (25) have found an influence of medication on neopterin levels, this question can not be answered conclusively by this study.
Other factors that could cause alterations in neopterin concentrations include influences of changing neurotransmitter synthesis. Tetrahydrobiopterin, a compound closely linked to neopterin-biosynthesis, has an important function as a cofactor for phenylalanine and tryosine hydroxylase in the production of dopamine. Again this is rather unlikely, as antipsychotics, which clearly alter dopamine turnover have little or no influence on neopterin levels (9) . Secondary factors, so-called epiphenomena, such as influences due to sleep disturbance or stress caused by the symptoms of acute psychosis must also be taken into account. Stress for instance has been shown to decrease neopterin in patients with anxiety disorders (27) .
Main limitations of this study are the small sample size and the heterogenous antipsychotic medication procedure prior to hospital admission. On the other hand, it must be mentioned that these results are in line with data of our previous investigations (9, 24) Summarizing the neopterin results of this study, the data do not support an activation of CMI m schizophrenia but to the contrary, give some hints for at least a low or possibly subnormal immunologic activation level in the acute stage of schizophrenic illness. This is backed up by the kynurenine findings of this investigation showing the same development as neopterin namely not presenting remarkable elevations which would be expected in a state of immune stimulation due to an acceleration of the kynurenine pathway metabolism (19, 20) .
When interpreting the tryptophan data one has to keep in mind that tryptophan is substrate for two enzymic pathways: (1) tryptophan-5-hydroxylase converting tryptophan to 5-hydroxy-tryptophan which is the precursor of 5-hydroxy-tryptamine (serotonin) and (2) tryptophan pyrrolase which together with indoleamine (2, 3)-dioxygenase (IDO), catalyses the degradation of tryptophan via the kynurenine pathway.
The activity of tryptophan-5-hydroxylase as well as degradation of tryptophan by IDO are both directly and indirectly associated with immune activation. IFN-γ, released during states of immune activation, will activate GTP-cyclohydrolase I, the key enzyme for the biosynthesis of pteridines (15) . In most cells this leads to an increased formation of 5, 6, 7, 8-tetrahydrobiopterin and initiates the production of serotonin if tryptophan-5-hydroxylase is present (28) . Large amounts of neopterin are formed at the expense of tetrahydrobiopterin in human monocytes/macrophages (15, 16) . Again, the relatively stable tryptophan levels we found do not support an acute state of CMI activation. Small fluctuations of tryptophan levels might be due to changes in nutrition, assuming that some acutely ill schizophrenic patients do not cat regularly before hospital admission. When admitted they eat regular meals containing all essential amino acids including tryptophan.
There was little variation in T-cell subsets in this study. This could be explained by the small sample size, as the results go in the same direction as those found in a bigger sample in which statistical differences could be seen. In this previous study total T-lymphocytes (CD3+) and T-helper cells (CD4+) were highest in the acute stage of schizophrenic psychosis whereas remitted patients showed normal values. In contrast, NK-cells were found lowest in acutely ill patients followed by a normalization with the remisson of psychosis. This was seen in neuroleptic naive patients as well as in medicated ones.
The results of this and two previous studies (9, 24) support an immune dysfunction in the acute stage of schizophrenia characterized by low or subnormal neopterin, low kynurenine, low NK-cells, elevated CD3+/CD4+ cells and fairly unchanged tryptophan Pteridines/Vol. 13/No. 1 levels. Immunological findings, such as reduced NKactivity, low IL-2 and IFN-γ production, reported by other groups, also support this immune dysfunction hypothesis. In the light of the subclassification of Thelper (CD4+) cells into TH-1 and ΤΉ-2 cells (29) , it is tempting to speculate that the observations mentioned above are due to a change in the balance of the TH-1 and TH-2 axes. According to the TH-l/TH-2 paradigm, by which TH-1 and TH-2 cells-derived cytokines negatively regulate the production of each other, a suppression of TH-1 cell activity and a strengthening of TH-2 mediated immune function should cause decreased IL-2, IFN-γ and macrophage activity (30) . Consequently, one could assume that IL-12 production by macrophages is also impaired, thus leading to a decreased proliferation and activity of NKcells. On the other hand, a decreased amount of NKcells could also be a reason for -and not only result from-a shift from TH-1 to TH-2 typ immune response, because NK-cells also represent a major source for the production of IFN-γ. In this case the imbalance of TH-1 and TH-2 would be due to the impaired IFN-γ production, Yet, another explanation of these findings could be a stimulation of TH-2 type immune function by a still to unknown mechanism (11) .
Viral infections have been discussed in the etiopathogenesis of schizophrenia. Our findings of normal or even decreased neopterin and kynurenine levels in patients with acute symptomatology argue against an acute infection at the time of acute psychosis but the data could be interpreted as a shift from TH-1 to TH-2 type immune reaction as it is very common in chronic infections. No viral parameters have been examind in this study. During treatment an increase or a normalization of neopterin production and tryptophan degradation seemed to occur, thereby indicating that the ΤΗ-2 type reaction is slowed down during therapy and the down-regulated TH-1 type immunity is normalizing. Thus, our data could be well explained on the basis of a chronic rather than an acute viral infection in schizophrenia.
